{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:14:34Z","timestamp":1759961674496},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156706","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T17:43:16Z","timestamp":1464889396000},"page":"e0156706","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors Influencing the Placebo Effect in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: An Analysis of Two Randomized Clinical Trials"],"prefix":"10.1371","volume":"11","author":[{"given":"Taichi","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"9774","key":"ref1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"HA Quigley","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"YH Kwon","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"A Heijl","year":"2002","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"MC Leske","year":"2003","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"MA Kass","year":"2002","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"key":"ref6","article-title":"Primary Open-Angle Glaucoma Suspect","year":"2010"},{"key":"ref7","first-page":"f3518","article-title":"Glaucoma","volume":"346","author":"A King","year":"2013","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9394(75)90792-8","article-title":"Diurnal variation of intraocular pressure in primary open-angle glaucoma","volume":"79","author":"Y Kitazawa","year":"1975","journal-title":"American journal of ophthalmology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9394(70)91628-4","article-title":"Seasonal variation in intraocular pressure","volume":"69","author":"M Blumenthal","year":"1970","journal-title":"American journal of ophthalmology"},{"key":"ref10","first-page":"310","article-title":"The clinical significance of diurnal pressure variation in primary open-angle glaucoma","volume":"23","author":"T Horie","year":"1979","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0301-0511(99)00012-5","article-title":"Intraocular pressure changes: the influence of psychological stress and the Valsalva maneuver","volume":"51","author":"S Brody","year":"1999","journal-title":"Biological psychology"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF01904906","article-title":"Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients","volume":"19","author":"G Kaluza","year":"1996","journal-title":"Journal of behavioral medicine"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"S Asrani","year":"2000","journal-title":"Journal of glaucoma"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ajo.2013.05.016","article-title":"Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension","volume":"156","author":"H Tanihara","year":"2013","journal-title":"American journal of ophthalmology"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9394(14)72009-4","article-title":"A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group","volume":"122","author":"E Strahlman","year":"1996","journal-title":"American journal of ophthalmology"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.0000000000001282","article-title":"Placebo effect of medication cost in Parkinson disease: a randomized double-blind study","volume":"84","author":"AJ Espay","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jamapsychiatry.2014.1319","article-title":"Placebo response in antipsychotic clinical trials: a meta-analysis","volume":"71","author":"BR Rutherford","year":"2014","journal-title":"JAMA psychiatry"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urology.2014.04.011","article-title":"Examination of the significant placebo effect in the treatment of interstitial cystitis\/bladder pain syndrome","volume":"84","author":"PC Bosch","year":"2014","journal-title":"Urology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"K Sall","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000381782","article-title":"Techniques to Reduce the Placebo Effect in Glaucoma Clinical Trials","volume":"54","author":"RA Sharpe","year":"2015","journal-title":"Ophthalmic research"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bjophthalmol-2012-302046","article-title":"Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials","volume":"97","author":"RA Sharpe","year":"2013","journal-title":"The British journal of ophthalmology"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/02713683.2014.946519","article-title":"The placebo effect in early-phase glaucoma clinical trials","volume":"40","author":"RA Sharpe","year":"2015","journal-title":"Current eye research"},{"key":"ref23","first-page":"1303","article-title":"An Exploratory Study of Brimonidine Ophthalmic Solution in Patients with Primary Open Angle Glaucoma or Ocular Hypertension","volume":"29","author":"M Araie","year":"2012","journal-title":"Journal of the eye"},{"key":"ref24","first-page":"429","article-title":"The Glaucomas","author":"R Zeimer","year":"1996"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000027290","article-title":"Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects","volume":"212","author":"SC Sacca","year":"1998","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10384-006-0343-z","article-title":"Diurnal variation of intraocular pressure in suspected normal-tension glaucoma","volume":"50","author":"K Hasegawa","year":"2006","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ophtha.2010.04.027","article-title":"Short-term repeatability of diurnal intraocular pressure patterns in glaucomatous individuals","volume":"118","author":"T Realini","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1542-0124(12)70004-6","article-title":"Challenges and pitfalls in clinical trials of treatments for dry eye","volume":"1","author":"GN Foulks","year":"2003","journal-title":"The ocular surface"},{"issue":"7004","key":"ref29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bmj.311.7004.551","article-title":"Concept of true and perceived placebo effects","volume":"311","author":"E Ernst","year":"1995","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"ref30","first-page":"27","article-title":"Association of blood pressure and body mass index with intraocular pressure in middle-aged and older Japanese residents: a cross-sectional and longitudinal study","volume":"68","author":"M Yoshida","year":"2014","journal-title":"Acta medica Okayama"},{"issue":"2","key":"ref31","first-page":"133","article-title":"Epidemiology of glaucoma in Japan\u2014a nationwide glaucoma survey","volume":"35","author":"Y Shiose","year":"1991","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0002-9394(00)00930-2","article-title":"Washout periods for brimonidine 0.2% and latanoprost 0.005%","volume":"131","author":"WC Stewart","year":"2001","journal-title":"American journal of ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T13:18:52Z","timestamp":1540041532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156706"}},"subtitle":[],"editor":[{"given":"James Fielding","family":"Hejtmancik","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156706","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}